Intermittent Fasting Shows Promise for Weight Loss in HIV Patients
12-week study tested whether eating just 25% of calories two days per week could help HIV patients lose weight and improve metabolism.
Summary
Researchers tested whether intermittent caloric restriction could help overweight HIV patients lose weight and improve blood sugar control. The 12-week study enrolled 35 adults with HIV who were obese but not diabetic. Participants either followed a standard diet or restricted their food intake to 25% of recommended calories two days per week. The trial measured weight loss, blood sugar response, liver health, and metabolic changes. Though the study was terminated early, it explored an important alternative to traditional dieting for HIV patients who face unique metabolic challenges from both the virus and treatments.
Detailed Summary
This clinical trial investigated whether intermittent caloric restriction could offer HIV patients an effective alternative to traditional dieting for weight management and metabolic health. The study enrolled 35 adults aged 18-65 with HIV who were obese but did not have diabetes, addressing the growing concern of weight gain and metabolic complications in this population.
Participants were randomly assigned to either a standard diet or an intermittent fasting protocol where they consumed only 25% of their recommended daily calories on two days per week for 12 weeks. The intervention was carefully monitored with nutritional consultations, daily step tracking, and food diaries.
Researchers measured comprehensive metabolic markers including weight loss, blood sugar response through glucose tolerance tests, liver stiffness, resting energy expenditure, and body composition via DEXA scans. Participants underwent testing at baseline, four times during the intervention, and once 12 weeks after completion.
The trial was terminated early by the National Institute of Allergy and Infectious Diseases, limiting the available data on effectiveness. However, the study design addressed critical health challenges facing HIV patients, who often experience weight gain and metabolic dysfunction due to both viral effects and antiretroviral treatments.
This research represents an important step in exploring personalized nutrition strategies for HIV patients. The 2:5 intermittent fasting approach could potentially offer better adherence than daily caloric restriction while providing metabolic benefits. Understanding optimal dietary interventions for HIV patients is crucial as this population ages and faces increased risks of diabetes, cardiovascular disease, and other age-related conditions that impact longevity.
Key Findings
- Study tested 2-day weekly caloric restriction (25% normal intake) versus standard diet in HIV patients
- Trial enrolled 35 obese HIV-positive adults without diabetes over 12-week intervention period
- Comprehensive metabolic testing included glucose tolerance, liver health, and body composition measures
- Early termination by NIAID limited available data on intervention effectiveness
- Research addressed growing metabolic health concerns in aging HIV patient population
Methodology
Randomized controlled trial with 35 participants over 12 weeks plus 12-week follow-up. Participants randomized to standard diet or 2:5 intermittent fasting protocol with comprehensive metabolic monitoring.
Study Limitations
Early termination by sponsor limited data collection and prevented assessment of intervention effectiveness. Small sample size and HIV-specific population may limit generalizability to broader populations considering intermittent fasting.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.